Q2 2022 Holdings
Filed 2022-07-15 | 8 holdings | $20.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $20.5M | 1,798,163 | 99.5% |
| Kinnate Biopharma, Inc. | Common Stock | 49705R105 | $34.6K | 2,747,433 | 0.2% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $20.3K | 2,960,046 | 0.1% |
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $19.1K | 3,931,818 | 0.1% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $10.1K | 2,765,314 | 0.0% |
| Praxis Precision Medicines, Inc. | Common Stock | 74006W108 | $7.2K | 2,939,329 | 0.0% |
| LianBio | Ordinary Shares | 53000N108 | $4.9K | 2,282,084 | 0.0% |
| Homology Medicines, Inc. | Common Stock | 438083107 | $1.5K | 770,845 | 0.0% |